Aug 28
Notre Dame’s PD[N]ano Lab awarded a sole-source Defense Health Agency contract to supply phage-mimicking nanoparticles to the Walter Reed Army Institute of Research In 2025, the U.S. Army’s acquisition office did something it does routinely when it needs a capability the military doesn’t yet have: it asked the world. A Request for Information titled “Antibacterial …
Mar 28
The Society For Biomaterials (SFB) 2026 Annual Meeting & Exposition brought our lab to the Hyatt Regency Atlanta from March 25–28, 2026, and it was one of the most rewarding conferences for us this year. The lab had three contributions spanning our antibiofilm-coating, antimicrobial drug-delivery, and cancer-theranostic programs, and I was particularly honored to be …
Aug 30
Dr. Nallathamby presented on his abiotic biomimicking antibacterial Nanoparticles, and how they were successfully tested against A. baumannii BA1605 S.aureus USA300, P.aeruginosa FRD1, K. pneumoniae, C.striatum, E. faecalis, and S. pyogenes. We saw little to no evolution of resistance at doses above the MIC. Additionally, we observed what looks like inflammation-free wound healing in mouse and rat models. The wound size stabilizes as soon as the formulation is …
Aug 21
Congratulations to REUs Argerie Guevara (NURF’21), and Kevin Armknecht (NURF’23) and Carlie Kudary (#BIPH) on the prolonged antibacterial action formulation of standard antibiotics to tackle MRSA and P.aeruginosa. More to come this year. #AMR #GOIRISH https://doi.org/10.1093/milmed/usae079
May 24
Really useful information on working with the DoD’s medical enterprise. MTEC annual meeting in Baltimore, MD. Phage Mimicking antibacterial nanoparticles was a hit. New Partnering opportunity on the horizon. Exciting times ahead! #GOIRISH #MTEC #AMR #NEXTGEN #ANTIBIOTICS
May 07
Notre Dame senior Kevin Armknecht, affiliated with the Berthiaume Institute for Precision Health, has earned the Best Publication Imaging Award from ND’s Integrated Imaging Facility (NDIIF) for images he contributed to a recent Nanoscale Advances publication. Armknecht, who is majoring in pre-professional studies with minors in compassionate care in medicine and poverty studies, produced these …
Mar 01
Our manuscript titled, “PLGA nanoparticles formulations loaded with antibiotics induce sustained and controlled antibiotics release for prolonged antibacterial action against MRSA, and Pseudomonas aeruginosa FRD1” (MILMED-D-23-00750R1), has been accepted for publication. This is the first time we are publishing in the supplement to the Military Health Sciences Research Symposium. The manuscript was based on our …
Nov 16
In recent combat theaters, despite advances in treating critical injuries leading to higher survival rates, there has been an increase in the number of infections linked to trauma, particularly those caused by bacteria resistant to multiple drugs 1,2. Research from the Trauma Infectious Disease Outcomes Study indicates that 27% of those evacuated with injuries develop …
May 14
Our research looks at the basic mechanism of drug resistance in bacteria or cancer cells and then we work on translational solutions to combat these problems. Our approach felt validated at this meeting where we networked with industry end-users as well as disease-on-a chip modeling academicians.
NIH Funding Opportunities
Recent Comments